Tender detail
Supply of Enfortumab
Summary
The tender concerns the supply of Enfortumab in the antineoplastic agents category. This is an open procedure for supplies with an estimated value of EUR 2,766,115. The machine-readable notice did not include precise qualification, exclusion or compliance requirements; these must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.